Protect
American
Seed Genetics.
On November 12, 2026, a buried clause in the FY2026 Ag Appropriations Act starts treating cannabis seeds as a DEA Schedule I controlled substance, based on the parent plant they came from. Help ASIGA strike it.
“Cannabis seeds do not produce THC. Yet under Section 781(1)(C)(i), even seeds that test below 0.3% THC can be criminalized because of the parent plant.”
Three Pillars Under Threat
Innovation
Section 781(1)(C)(i) regulates seeds by the THC of their parent plant, not the seed itself. For seeds already in lawful possession on Nov 12, 2026, the parent no longer exists to be tested, meaning no compliance pathway exists at any cost. Decades of breeding work would be frozen overnight.
Genetic Diversity
Cannabis seeds contain no meaningful THC. Cannabinoid biosynthesis happens only in glandular trichomes, tissues seeds do not contain. Yet the provision would criminalize seeds that test below 0.3% THC purely because of their lineage, wiping out seed banks and germplasm collections preserved for generations.
American Leadership
No major trading partner regulates cannabis seed by parent-plant traceability. As other countries open their markets, the US would impose a compliance burden nobody else does. The likely result: long-term leadership in cannabis genetics moves to Europe, Israel, and Canada permanently.
The Path To November 12
- November 12, 2025
FY2026 Ag Appropriations Act signed into law
President signs the FY2026 Agriculture Appropriations Act, which quietly contains Section 781(1)(C)(i). The provision is on a 12-month delay before taking effect.
- May 2026
ASIGA forms and publishes technical brief
The American Seed Innovation & Growth Alliance organizes, releases its two-page issue brief, and launches a GoFundMe to support lobbying and legal work in Washington.
- Summer & Fall 2026 · Happening Now
Lobbying window
ASIGA pushes Congress to strike Section 781(1)(C)(i) before the effective date, while building public support and media coverage.
- November 12, 2026
Provision takes effect
Without congressional action, cannabis seeds whose parent plant tested above 0.3% THC become DEA Schedule I controlled substances, subject to destruction and federal penalties.
What's On The Table
How Section 781(1)(C)(i) Works
The provision excludes from the federal hemp definition “any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration of 0.3 percent in the plant on a dry weight basis.” The result: those seeds become DEA Schedule I controlled substances, subject to mandatory destruction and federal penalties.
For the first time in US hemp law, a material's legal status would be determined not by what it is, but by where it came from.
- Seeds reclassified as a DEA Schedule I controlled substance
- Seed banks and research institutions holding tens of thousands of seeds become subject to mandatory destruction
- Interstate commerce in cannabis seeds effectively ends
- Patients lose access to CBD:THC ratios for seizure management and low-THC, high-CBG cultivars for chronic pain
- Veterans and patients across the 47 states with medical cannabis programs cut off from established varieties
- Small rural seed businesses, banking, and credit processing for the industry severely disrupted
- US breeders surrender the global cannabis genetics market at the moment they were scaling to lead it
What Actually Changes
Six dimensions of US seed law before and after Section 781(1)(C)(i) takes effect.
| Aspect | Today (2018 Farm Bill) | After Nov 12, 2026 |
|---|---|---|
| Legal status of seed | Hemp under federal law if the seed itself tests at or below 0.3% THC (per 2018 Farm Bill). | DEA Schedule I controlled substance if the parent plant exceeds 0.3% THC, regardless of the seed's own chemistry. |
| What gets tested | The seed. | The parent plant, which may no longer exist for already-held germplasm. |
| Interstate commerce | Permitted for compliant hemp seed. | Effectively halted; federal law preempts state markets. |
| Enforcement | USDA jurisdiction under hemp framework. | Shared USDA + DEA jurisdiction with seed destruction and federal penalties. |
| Patient access | Stabilized cultivars move legally between state programs. | Specific CBD:THC and CBG cultivars become inaccessible across state lines. |
| US global position | American breeders well-positioned to lead the global cannabis genetics market. | Compliance burden no trading partner imposes; leadership shifts to Europe, Israel, Canada. |
Who's Affected
Cannot legally develop, store, or distribute most new cultivars. Decades of breeding work in question.
Lose interstate access to seed stock. The $739M US hemp economy and $49.7M dedicated seed industry directly threatened.
Holdings of tens of thousands of seeds become Schedule I overnight, with no compliance pathway for already-held germplasm.
Across 47 states + DC, patients reproducing specific cultivars for seizure or pain management lose access to the genetics their care depends on.
Veterans using cannabis for chronic pain, PTSD, and sleep lose access to specific CBD:THC and high-CBG cultivars.
Across ~25 jurisdictions that authorize home cultivation, growers can no longer source seed legally across state lines.
Banking, credit card processing, and financing for seed businesses disrupted by Schedule I status.
Required to build new traceback systems and enforcement programs without dedicated appropriations.
Real People Lose Real Medicine
Registered patients across the 47 states with medical cannabis programs reproduce specific cultivars from seed to maintain consistent cannabinoid profiles. That includes CBD:THC ratios for seizure management and low-THC, high-CBG cultivars for inflammatory and neuropathic pain.
Section 781(1)(C)(i) would withdraw the federally compliant pathway for those seeds, at the same moment federal rescheduling expands medical recognition. Veterans, seizure patients, and chronic pain patients lose access to the specific genetics their stabilized care depends on.
What ASIGA Is Doing
For months, ASIGA has been building a serious policy and lobbying effort, supported by experienced hemp advocates, former USDA officials, and communications specialists who understand how to influence legislation at this level.
ASIGA's proffered remedy is direct: strike Section 781(1)(C)(i) in its entirety. Seeds are already covered by the base hemp definition under the 2018 Farm Bill. If a seed tests at or below 0.3% THC, it is hemp under federal law. The seed provision is not needed to accomplish Section 781's stated purpose.
The coalition spans industrial hemp, seed genetics, and home-grow. Its work in Washington is focused squarely on protecting an American industry, American jobs, and American leadership in plant science.
Key Terms Defined
- Section 781(1)(C)(i)
- A provision of the FY2026 Agriculture Appropriations Act that excludes from the federal hemp definition any viable seeds from a Cannabis sativa L. plant exceeding 0.3% total THC on a dry-weight basis. Effective November 12, 2026.
- DEA Schedule I
- The most restrictive classification under the Controlled Substances Act, reserved for substances with high abuse potential and no accepted medical use. Possession and distribution carry federal criminal penalties.
- Cannabis sativa L.
- The scientific name for the cannabis plant species. The Linnaean species designation includes both hemp (≤ 0.3% THC) and high-THC cannabis under current federal law.
- Trichomes
- The resin-producing glandular structures on cannabis flowers and leaves where cannabinoid biosynthesis occurs. Seeds do not contain trichomes and therefore do not produce THC.
- 2018 Farm Bill
- The Agriculture Improvement Act of 2018, which legalized hemp federally by defining hemp as Cannabis sativa L. containing 0.3% or less THC. The base definition that Section 781(1)(C)(i) overlays.
- Total THC
- The sum of delta-9 tetrahydrocannabinol and tetrahydrocannabinolic acid (THCA) after a conversion factor. The metric Section 781 uses to evaluate parent-plant compliance.
- Traceback
- A regulatory chain-of-custody system tracing a seed back to the specific parent plant it came from. Required by Section 781(1)(C)(i) but generally impossible to enforce for existing germplasm.
Common Questions
What exactly is Section 781(1)(C)(i)?+
A provision in the FY2026 Agriculture Appropriations Act, signed into law Nov 12, 2025 and taking effect Nov 12, 2026. It excludes from the federal hemp definition any viable Cannabis sativa L. seeds whose parent plant exceeds 0.3% total THC on a dry-weight basis. The result is that those seeds become DEA Schedule I controlled substances, subject to destruction and criminal penalties.
Why is this an unprecedented standard?+
For the first time in US hemp law, a material's legal status would be determined not by what it is, but by where it came from. No other agricultural commodity is regulated this way. There is no federal rule that classifies wheat seed by the alcohol content of the beer it could be brewed into, or corn seed by aflatoxin levels in its parent field. Section 781(1)(C)(i) breaks from this established principle without precedent.
Can the regulation even be enforced?+
ASIGA's brief argues no. Traceback requires testing the living parent plant, which depends on field location, temperature, and days to harvest. For seeds already in lawful possession on the effective date, the parent plant no longer exists to be tested. No regulation USDA could issue can supply a compliance pathway for material already in lawful commerce.
What is ASIGA's proposed remedy?+
Strike Section 781(1)(C)(i) in its entirety. Seeds are already covered by the base hemp definition under the 2018 Farm Bill: if a seed tests at or below 0.3% THC, it is hemp under federal law. Section 781(1)(C)(i) is not needed to accomplish Section 781's stated purpose. Sections 781(1)(C)(ii) through (iv) already restrict intoxicating consumer products directly.
Who is ASIGA?+
The American Seed Innovation & Growth Alliance, a coalition spanning industrial hemp, seed genetics, and home-grow. It is supported by experienced hemp advocates, former USDA officials, and communications specialists working on Capitol Hill.
Why is the deadline November 12, 2026?+
The FY2026 Agriculture Appropriations Act was signed into law on November 12, 2025 with a 12-month delay before Section 781 takes effect. Congress can amend or strike the provision at any time before that date.
Will my existing seeds become illegal overnight?+
Under the provision as written, yes. There is no grandfather clause for germplasm in lawful possession on the effective date, and no compliance pathway exists because the parent plant typically no longer exists to be tested. This is one of ASIGA's central arguments for striking the provision.
How does this affect medical patients?+
Patients in the 47 states with medical cannabis programs commonly reproduce specific cultivars from seed to maintain consistent cannabinoid and terpene profiles. CBD:THC ratios for seizure management and low-THC, high-CBG cultivars for chronic pain depend on continuous seed availability. Section 781(1)(C)(i) ends the federally compliant interstate pathway for those seeds.
How can I help?+
Donate to the GoFundMe to fund ASIGA's lobbying, legal, and communications work. Read the technical brief and share it. Awareness before the November 12, 2026 deadline is the single most important variable.
166 Days Left.
Make Them Count.
ASIGA's lobbying, legal, and communications work runs on donations. Every dollar and every share moves this closer to striking the provision before November 12.
218 Cultivation is sharing this in support of ASIGA via our affiliate partner Seedsman. Signed into law November 12, 2025. Effective November 12, 2026. Donations go directly to the ASIGA GoFundMe. The technical brief is published by the American Seed Innovation & Growth Alliance at asiga.org.